Global Electroporation Instruments Market – Industry Trends and Forecast to 2029

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Electroporation Instruments Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Electroporation Instruments Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
2022 –2029
Diagram Market Size (Base Year)
USD 769.00 Million
Diagram Market Size (Forecast Year)
USD 1,447.80 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Electroporation Instruments Market, By Product Type (Instruments, Accessories), Application (Protein Production, Therapeutic Delivery, Biomedical Research), End User (Hospital Laboratories, Research and Academic Institutes, Biotechnology or Pharmaceutical Industries) – Industry Trends and Forecast to 2029.

Electroporation Instruments Market

Global Electroporation Instruments Market Analysis and Size

Technological improvements and research and innovation operations have been critical in bringing about significant changes in the healthcare industry. The introduction of new technologies has paved the way for cutting-edge medical gadgets to be employed to treat a wide range of medical ailments and conditions. Major changes have happened in the electroporation instruments market landscape over the last two decades, as industry participants continue to focus on enhancing the efficiency and performance of their products. Electroporation is a well-known physical technique for introducing polar materials, such as DNA, into eukaryotic cells via the cell membrane.

  • Data Bridge Market Research analyses that the electroporation instruments market was valued at USD 769 million in 2021 and is expected to reach USD 1,447.80 million by 2029, registering a CAGR of 8.23% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Electroporation Instruments Market Definition

Electroporation is a valuable molecular biology technique for non-chemical transformation of bacteria and yeasts and tissue culture cell transfection. Electroporation technologies produce high-intensity electric fields to cells in brief bursts. The cell membrane becomes more permeable as a result of the electrical field. Chemicals including medications and genetic material can now enter through the cell membrane, which would usually be impervious. Electroporation is a common approach for delivering foreign genes into target cells because of its ease of use and effectiveness.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Instruments, Accessories), Application (Protein Production, Therapeutic Delivery, Biomedical Research), End User (Hospital Laboratories, Research and Academic Institutes, Biotechnology or Pharmaceutical Industries)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Lonza (Switzerland), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), BEX Co. Ltd. (Japan), Celetrix LLC (US), Eppendorf AG (Germany), Harvard Bioscience Inc. (US), MaxCyte Inc. (US), Mirus Bio LLC. (US), Biotron Healthcare (Mumbai), AcceGen (US)

Market Opportunities

  • Increase in the number of emerging markets
  • Increase in the number of strategic collaborations
  • Rising investment for the development of advanced technologies

Electroporation Instruments Market Dynamics

Drivers

  • Increasing prevalence of chronic diseases

The rising prevalence of chronic diseases such as cancer, HIV and others will propel the market’s growth rate during the forecast period of 2022-2029. Vaccine delivery, gene delivery, and drug administration by electro-chemotherapy, such as bleomycin, are all common uses for electroporation devices in cancer treatment. Vaccines can also be used to treat infectious diseases such as the Human Immunodeficiency Virus (HIV).

  • Rise in the demand for monoclonal antibodies

The market is expected to develop in response to rising demand for monoclonal antibodies. Monoclonal antibodies are one of the pharmaceutical industry's fastest-growing products. In the fields of biology, diagnostic imaging, medicine, and biochemistry, they have a wide range of uses.

Furthermore, the rising awareness of various electroporation instruments in molecular biology sector will influence the growth of electroporation instruments market. Along with this, increasing urbanization and rising level of disposable income are the driving factors accelerating the growth of the electroporation instruments market. Also, increasing expenditure on healthcare infrastructure and favourable reimbursement scenario are the major market drivers that will further escalate the growth of electroporation instruments market.

Opportunities

  • Increase in the number of strategic collaborations or acquisitions       

Market participants are implementing initiatives such as collaborations, partnerships, and acquisitions, which are expected to boost the worldwide electroporation instruments market's growth over the forecast period. This will provide beneficial opportunities for the electroporation instruments market growth.

Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will further provide beneficial opportunities for the growth of electroporation instruments during the forecast period.

Restraints/Challenges Global Electroporation Instruments Market

On the other hand, the high cost associated with the instruments will obstruct the market's growth rate. The dearth of skilled professionals and strict government regulations will challenge the electroporation instruments market. Additionally, impact of COVID-19 on supply chain will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This electroporation instruments market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the electroporation instruments market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Electroporation Instruments Market

The COVID-19 outbreak and subsequent lockdown in several nations throughout the world had a financial impact on enterprises in all sectors, including the private healthcare sector. The COVID-19 pandemic significantly influenced the healthcare industry's whole supply chain, owing to stringent lockdown in certain places. Due to the use of electroporation in delivering vaccines and medications for the treatment of COVID-19, the pandemic may have a favourable impact and increase the growth of the worldwide electroporation instruments market throughout the forecast period.

Electroporation has been shown to significantly impact vaccine immunogenicity and efficacy. This is because, as compared to naked DNA delivery technologies alone, it has the potential to boost antigen delivery by up to 1000-fold. Compared to DNA delivery via direct injection alone, the increase in antigen delivery resulted in a bigger amplitude of immune response and higher response rates.

Global Electroporation Instruments Market Scope

The electroporation instruments market is segmented on the basis of product type, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Instruments
  • Accessories

Based on product type, electroporation instruments market is segmented into instruments and accessories. Instruments is further segmented into total electroporation system, transfection system, and microbial electroporation system. Accessories is further segmented into electroporated cuvettes, electrodes, volume chambers, and others

Application

  • Protein Production
  • Therapeutic Delivery
  • Biomedical Research

Based on application, electroporation instruments market is segmented into protein production, therapeutic delivery, and biomedical research.

End User

  • Hospital Laboratories
  • Research and Academic Institutes
  • Biotechnology or Pharmaceutical Industries

Electroporation instruments market has also been segmented based on the end user into laboratories, research and academic institutes, and biotechnology or pharmaceutical industries.

Electroporation Instruments Market Regional Analysis/Insights

The electroporation instruments market is analysed and market size insights and trends are provided by country, product, nature, site and end user as referenced above.

The countries covered in the electroporation instruments market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the electroporation instruments market because of the well-established healthcare infrastructure and highly sophisticated research labs in this region. Additionally, presence of major key players will flourish the market’s growth rate in this region. 

Asia-Pacific is expected to grow during the forecast period of 2022 to 2029 due to rising number of research and development facilities and development of healthcare sector this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The electroporation instruments market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for electroporation instruments market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the electroporation instruments market. The data is available for historic period 2010-2020.

Competitive Landscape and Electroporation Instruments Market Share Analysis

The Electroporation instruments market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to electroporation instruments market.

Some of the major players operating in the electroporation instruments market are:

  • Lonza (Switzerland)
  • Thermo Fisher Scientific Inc. (US)
  • Merck KGaA (Germany)
  • Bio-Rad Laboratories, Inc. (US)
  • BEX Co. Ltd. (Japan)
  • Celetrix LLC (US)
  • Eppendorf AG (Germany)
  • Harvard Bioscience Inc. (US)
  • MaxCyte Inc. (US)
  • Mirus Bio LLC. (US)
  • Biotron Healthcare (Mumbai)
  • AcceGen (US)

Research Methodology : Global Electroporation Instruments Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-electroporation-instruments-market


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Market Value for Electroporation Instruments Market is expected USD 1,447.80 million by 2029.
The Electroporation Instruments Market is to Grow at a CAGR of 8.23% During the Forecast Period of 2022 to 2029.
Lonza (Switzerland), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), BEX Co. Ltd. (Japan), Celetrix LLC (US), Eppendorf AG (Germany) are the Major Companies Operating in Electroporation Instruments Market.
The Countries Covered in the Electroporation Instruments Market Report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Electroporation Instruments Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.